SAFC Financials 07/15/2014 19:09:25 SafeCode Drug
Post# of 5
SafeCode Drug Technologies Corp.
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development - - -
Sales, General and Admin. 242 42 10
Non-Recurring Items 1,800 - 1
Other - - -
Operating Income (2,042) (42) (12)
Income From Continuing Operations
Add'l Income/Expense Items (15) - -
Earnings Before Interest and Tax (2,057) (42) (12)
Interest Expense 7 - -
Earnings Before Tax (2,064) (42) (12)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (2,064) (42) (12)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (2,064) (42) (12)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (2,064) (42) (12)